Gao H L, Liu L, Wang W Q, Yu X J
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Zhonghua Wai Ke Za Zhi. 2018 Nov 1;56(11):809-812. doi: 10.3760/cma.j.issn.0529-5815.2018.11.003.
Neuroendocrine tumors(NET) is a rare tumor with high heterogeneity.Pancreatic NET is the most common type in China. European Neuroendocrine Tumor Society(ENETS) has launched the ENETS guidelines since 2006 and published the ENETS standard of care in 2009. With the newly targeted therapies and further research on NET, 2017 new edition of the ENETS standard of care has changed a lot in the diagnosis and treatment of NET. This article explains the update of pancreatic NET in the 2017 edition of the ENETS standard of care, and introduces pancreatic NET from pathology, imaging examination, surgery, systemic therapy, etc., and deepens the understanding of the diagnosis and treatment of pancreatic NET.
神经内分泌肿瘤(NET)是一种异质性很高的罕见肿瘤。胰腺NET是中国最常见的类型。欧洲神经内分泌肿瘤学会(ENETS)自2006年起发布了ENETS指南,并于2009年公布了ENETS治疗标准。随着NET新型靶向治疗方法的出现以及对其进一步研究,2017年新版ENETS治疗标准在NET的诊断和治疗方面有了很大变化。本文阐述了2017年版ENETS治疗标准中胰腺NET的更新内容,并从病理学、影像学检查、手术、全身治疗等方面介绍胰腺NET,加深对胰腺NET诊断和治疗的理解。